TY - JOUR AU - Liu, Xiaoyan AU - Swen, Jesse J AU - Boven, Epie AU - Castellano, Daniel AU - Gelderblom, Hans AU - Mathijssen, Ron H J AU - Rodriguez Antona, Cristina AU - GarcĂ­a-Donas, Jesus AU - Rini, Brian I AU - Guchelaar, Henk-Jan PY - 2017 DO - 10.18632/oncotarget.13597 SN - 1949-2553 UR - http://hdl.handle.net/20.500.12105/8486 AB - VEGFR1 rs9582036 and rs9554320 were previously reported the association with sunitinib progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC). Hereafter, the association of both single... LA - eng PB - Impact Journals KW - VEGFR1 KW - Meta-analysis KW - Metastatic renal cell carcinoma KW - Sunitinib KW - Validation study KW - Alleles KW - Antineoplastic Agents KW - Carcinoma, Renal Cell KW - Gene Frequency KW - Genotype KW - Humans KW - Indoles KW - Kidney Neoplasms KW - Neoplasm Metastasis KW - Polymorphism, Single Nucleotide KW - Prognosis KW - Proportional Hazards Models KW - Pyrroles KW - Sunitinib KW - Treatment Outcome KW - Vascular Endothelial Growth Factor Receptor-1 KW - Genetic Variation TI - Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients TY - journal article ER -